Peter Lamprecht Selected Research

Peter Lamprecht Research Topics

Disease

29	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 03/2024 - 05/2002
28	Vasculitis (Vasculitides) 04/2024 - 02/2004
17	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 04/2024 - 09/2004
14	Inflammation (Inflammations) 03/2024 - 05/2008
9	Autoimmune Diseases (Autoimmune Disease) 03/2024 - 01/2003
9	Churg-Strauss Syndrome (Allergic Angiitis) 04/2023 - 01/2005
8	Infections 02/2023 - 12/2009
6	Giant Cell Arteritis (Horton Disease) 06/2023 - 01/2005
6	Microscopic Polyangiitis 01/2023 - 01/2005
6	Systemic Vasculitis 01/2018 - 01/2005
4	Granuloma 06/2009 - 05/2002
3	Hypertension (High Blood Pressure) 06/2023 - 01/2010
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2023 - 01/2005
2	Fever (Fevers) 01/2023 - 01/2018
2	Disease Progression 11/2022 - 12/2005
2	IgA Vasculitis (Purpura, Schoenlein Henoch) 05/2022 - 01/2018
2	Systemic Scleroderma (Systemic Sclerosis) 01/2021 - 12/2018
2	Crohn Disease (Crohn's Disease) 04/2009 - 06/2006
2	Rheumatoid Arthritis 03/2009 - 01/2005
2	Connective Tissue Diseases (Connective Tissue Disease) 02/2006 - 01/2005
1	Nasopharyngitis 06/2023
1	Exanthema (Rash) 01/2023
1	Takayasu Arteritis (Arteritis, Takayasu's) 01/2023
1	Polyarteritis Nodosa (Periarteritis Nodosa) 01/2023
1	Schnitzler Syndrome 01/2023
1	Arthralgia (Joint Pain) 01/2023
1	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 01/2023
1	Peritoneal Panniculitis (Sclerosing Mesenteritis) 11/2022
1	Anti-Glomerular Basement Membrane Disease (Goodpasture's Syndrome) 05/2022
1	Rheumatic Diseases (Rheumatism) 01/2021
1	Cytopenia 01/2020
1	Agammaglobulinemia (Hypogammaglobulinemia) 01/2020
1	Ovarian Neoplasms (Ovarian Cancer) 12/2018
1	Alzheimer Disease (Alzheimer's Disease) 12/2018
1	Erdheim-Chester Disease 03/2018
1	Tertiary Lymphoid Structures 01/2018
1	Leukopenia 03/2016
1	Diabetes Mellitus 05/2013
1	Cataract (Cataracts) 05/2013
1	Osteoporosis 05/2013

Drug/Important Bio-Agent (IBA)

22	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 04/2024 - 02/2004
13	AutoantibodiesIBA 02/2023 - 03/2006
10	Myeloblastin (Proteinase 3)IBA 03/2024 - 02/2004
8	CytokinesIBA 10/2012 - 05/2002
6	Cyclophosphamide (Cytoxan)FDA LinkGeneric 03/2016 - 02/2004
5	Peptide Hydrolases (Proteases)FDA Link 03/2024 - 01/2010
5	AutoantigensIBA 02/2023 - 06/2006
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2009 - 05/2002
3	Peroxidase (Myeloperoxidase)IBA 03/2024 - 01/2010
3	C-Reactive ProteinIBA 01/2023 - 01/2011
3	Antigen-Antibody Complex (Immune Complex)IBA 01/2023 - 03/2006
3	AntibodiesIBA 01/2023 - 03/2009
3	Rituximab (Mabthera)FDA Link 01/2020 - 04/2006
3	Azathioprine (Imuran)FDA LinkGeneric 03/2006 - 09/2004
2	EnzymesIBA 03/2024 - 03/2016
2	AntigensIBA 03/2024 - 04/2023
2	GlucocorticoidsIBA 06/2023 - 01/2012
2	secukinumabIBA 06/2023 - 08/2021
2	Immunoglobulin G (IgG)IBA 01/2023 - 12/2018
2	Interferon-gamma (Interferon, gamma)IBA 08/2021 - 05/2002
2	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2013 - 02/2004
1	tocilizumab (atlizumab)FDA Link 06/2023
1	Monoclonal AntibodiesIBA 06/2023
1	Prednisolone (Predate)FDA LinkGeneric 06/2023
1	Environmental Pollutants (Pollutants, Environmental)IBA 02/2023
1	Immunoglobulin M (IgM)IBA 01/2023
1	Serum Amyloid A Protein (Serum Amyloid A)IBA 01/2023
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2023
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2023
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023
1	Complement System Proteins (Complement)IBA 01/2023
1	Complement C5a (Complement 5a)IBA 01/2023
1	elotuzumabIBA 11/2022
1	HMGB1 Protein (HMG1)IBA 01/2022
1	Contrast MediaIBA 08/2021
1	InterleukinsIBA 08/2021
1	Antimicrobial PeptidesIBA 06/2021
1	Interleukin-2 (IL2)IBA 01/2021
1	HLA-DQ Antigens (HLA-DQ)IBA 11/2019
1	Endothelin Receptors (Endothelin Receptor)IBA 10/2019
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 12/2018
1	Antinuclear AntibodiesIBA 03/2018
1	Antirheumatic Agents (DMARD)IBA 01/2018
1	Prednisone (Sone)FDA LinkGeneric 01/2018
1	Cytochrome P-450 CYP2C9IBA 03/2016
1	Cytochrome P-450 CYP2C19IBA 03/2016
1	ProdrugsIBA 03/2016
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 03/2016
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 10/2013
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 02/2012
1	Interleukin-7 (Interleukin 7)IBA 01/2012
1	Interleukin-15 Receptors (Interleukin 15 Receptor)IBA 01/2012
1	SuperantigensIBA 01/2010
1	PAR-2 ReceptorIBA 01/2010

Therapy/Procedure

14	Therapeutics 04/2024 - 02/2004
2	Biological Therapy 06/2023 - 04/2007
1	Immunotherapy 03/2024
1	Aftercare (After-Treatment) 08/2021
1	Extracorporeal Membrane Oxygenation 01/2021
1	Transplantation 05/2012